Avaí Bio, Inc.
AVAI
$0.17
-$0.02-8.81%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 53.91% | -22.23% | 7.10% | -205.06% | 202.16% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -58.86% | -18.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -1.15% | 166.80% | -68.84% | 136.07% | -322.14% |
| Cash from Operations | 85.36% | 6.57% | -54.60% | -28.16% | -39.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -50.85% | 51.36% | -0.24% | 32.95% | 228.82% |
| Total Debt Repaid | 200.00% | -170.95% | 200.00% | -- | -100.00% |
| Issuance of Common Stock | 290.83% | -58.25% | 139.50% | -44.29% | -18.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -92.27% | -32.64% | 167.71% | -36.20% | 95.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.38% | -150.79% | 215.35% | -191.03% | 5,900.00% |